Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond
Journal of Thoracic Oncology · 2023
DOI: 10.1016/j.jtho.2023.08.021 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Thoracic Oncology, 2023. Verfasst von Gulanbar Amori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Ja…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, Takeda Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic addres…
Förderung
- Japan Society for the Promotion of Science
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Foundation for Promotion of Cancer Research
- Yakult Bio-Science Foundation
- Japan Lung Cancer Society
Zitieren
APA
Amori, G., Sugawara, E., & Inamura, K. (2023). Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2023.08.021
Vancouver
Amori G, Sugawara E, Inamura K. Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond. Journal of Thoracic Oncology. 2023. doi:10.1016/j.jtho.2023.08.021
BibTeX
@article{Amori2023,
author = {Amori, Gulanbar and Sugawara, Emiko and Inamura, Kentaro},
title = {Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond},
journal = {Journal of Thoracic Oncology},
year = {2023},
doi = {10.1016/j.jtho.2023.08.021}
}
EUVIMED